| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.80B | +121.3% |
| Cost of Revenue | $2.46B | +126.1% |
| R&D Expense | $116.3M | +456.5% |
| Operating Income | $189.4M | +60.0% |
| Interest Expense | $114.4M | +489.7% |
| Pre-tax Income | -$62.4M | -165.5% |
| Income Tax | -$13.1M | -222.4% |
| Net Income | -$50.5M | -159.1% |
| EPS (Basic) | -$0.98 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.9M | -86.3% |
| Accounts Receivable | $442.9M | +84.8% |
| Inventory | $643.7M | +176.1% |
| Current Assets | $1.58B | -15.0% |
| Total Assets | $8.19B | +139.9% |
| Current Liabilities | $1.62B | +202.9% |
| Long-term Debt | $1.47B | +17.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | $458.1M | -18.5% |
| -136.7% |
| EPS (Diluted) | -$0.98 | -137.0% |
| Stockholders' Equity |
| $4.46B |
| +189.1% |